القيمة السوقية تغيير تاريخ
Acadia Pharmaceuticals USD 4.52B 919M 2025-12
ALKERMES USD 4.62B 333M 2025-12
Amgen USD 176.25B 24.32B 2025-12
Biogen USD 25.82B 5.28B 2025-12
Eisai JPY 1.31T 140.95B 2025-12
Enanta Pharmaceuticals USD 122M 98M 2024-12
Esperion Therapeutics USD 885M 351M 2025-12
Gilead Sciences USD 152.28B 14.55B 2025-12
Incyte USD 19.39B 2.83B 2025-12
Neurocrine Biosciences USD 14.14B 218M 2025-12
PTC Therapeutics USD 6.1B 1.22B 2025-12
Regeneron Pharmaceuticals USD 81.12B 21.53B 2025-12
Sarepta Therapeutics USD 2.26B 238M 2025-12
Supernus Pharmaceuticals USD 2.85B 151M 2025-12
UCB EUR 46.41B 13.94B 2025-12
Vertex Pharmaceuticals USD 115.03B 14.61B 2025-12